Bladder-only radiotherapy substantially irradiated adjacent pelvic nodes regardless of IMRT technique
Obturator nodes received about 75% of the prescribed bladder dose incidentally, with similar regional exposure from VMAT and fixed-field IMRT.
Obturator nodes received about 75% of the prescribed bladder dose incidentally, with similar regional exposure from VMAT and fixed-field IMRT.
Routine CT-based adaptive brachytherapy achieved 84.4% five-year local control despite 56.9% of patients having stage III–IV cervical cancer.
Ninety-five percent completed 55 Gy in 20 fractions, with encouraging outcomes in early p16-positive oropharyngeal cancer despite substantial acute toxicity.
Second-generation AI reduced rectal radiotherapy contouring time from 41 to 17 minutes while improving accuracy and consistency.
Environ showed less static-beam attenuation and lower vertical setup variability than Encompass while maintaining accurate HyperArc dose calculation.
Calibrated uncertainty thresholds kept gamma-defined dose-modelling failure below 10% while accepting 45–77% of irradiation segments.
Ten contemporary multimodal deep-learning studies showed inconsistent external performance, calibration and reporting, limiting clinical use of personalized toxicity prediction.
Median survival was 25 versus 18 months with chemotherapy plus definitive pelvic radiotherapy after propensity matching in stage IVB cervical cancer.
Daily adaptive salvage radiotherapy produced 6% new grade ≥2 urinary toxicity at 12 months in a prospective 51-patient cohort.
Mechanical ventilation reduced median liver motion from 29 mm during free breathing to 9 mm at 60 breaths per minute with PEEP.
Restricting deep VMAT apertures reduced heart and ipsilateral lung exposure across three linacs while maintaining comprehensive breast and nodal coverage.
Reduced-volume MR-guided RT caused no grade ≥3 toxicity, but two of ten patients developed in-field recurrence after five-fraction treatment.
FLASH protons largely preserved ocular structure and retinal function after 24 Gy while maintaining short-term tumor control in mice.
Four-year biochemical control was similar with 65 Gy in 26 fractions and 66 Gy in 33 fractions, while gastrointestinal toxicity was higher.
Across 187 fractions, surface-guided breath-hold IMPT remained highly stable, with only one patient requiring adaptive replanning.